BioLife Solutions (BLFS) Competitors $21.42 +0.38 (+1.81%) Closing price 04:00 PM EasternExtended Trading$21.43 +0.01 (+0.05%) As of 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. SLNO, TMDX, INSP, NVST, PRCT, WRBY, LIVN, EYE, NVCR, and LMATShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), NovoCure (NVCR), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Its Competitors Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics Warby Parker LivaNova National Vision NovoCure LeMaitre Vascular BioLife Solutions (NASDAQ:BLFS) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Do analysts prefer BLFS or SLNO? BioLife Solutions currently has a consensus price target of $31.17, suggesting a potential upside of 45.50%. Soleno Therapeutics has a consensus price target of $108.70, suggesting a potential upside of 24.03%. Given BioLife Solutions' higher possible upside, research analysts plainly believe BioLife Solutions is more favorable than Soleno Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Do institutionals and insiders hold more shares of BLFS or SLNO? 93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Comparatively, 6.4% of Soleno Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer BLFS or SLNO? In the previous week, Soleno Therapeutics had 5 more articles in the media than BioLife Solutions. MarketBeat recorded 8 mentions for Soleno Therapeutics and 3 mentions for BioLife Solutions. Soleno Therapeutics' average media sentiment score of 0.88 beat BioLife Solutions' score of 0.42 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Soleno Therapeutics 3 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is BLFS or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to BioLife Solutions' net margin of -11.81%. BioLife Solutions' return on equity of -0.66% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-11.81% -0.66% -0.58% Soleno Therapeutics N/A -77.52%-63.44% Which has better valuation & earnings, BLFS or SLNO? BioLife Solutions has higher revenue and earnings than Soleno Therapeutics. BioLife Solutions is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$87.76M11.68-$20.18M-$0.29-73.86Soleno TherapeuticsN/AN/A-$175.85M-$4.62-18.97 Which has more risk & volatility, BLFS or SLNO? BioLife Solutions has a beta of 1.79, suggesting that its share price is 79% more volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.63, suggesting that its share price is 363% less volatile than the S&P 500. SummarySoleno Therapeutics beats BioLife Solutions on 9 of the 16 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.02B$9.99B$5.50B$9.38BDividend YieldN/A2.06%4.25%4.06%P/E Ratio-73.8616.3128.1019.86Price / Sales11.6828.96380.1579.14Price / Cash169.6222.2335.5357.53Price / Book2.853.618.265.72Net Income-$20.18M$233.40M$3.24B$257.80M7 Day Performance-5.72%-3.35%0.50%1.07%1 Month Performance-1.47%4.19%7.99%11.31%1 Year Performance-4.84%-17.80%28.68%17.01% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.0233 of 5 stars$21.42+1.8%$31.17+45.5%-7.6%$1.02B$87.76M-73.86440SLNOSoleno Therapeutics4.179 of 5 stars$82.76+1.5%$108.70+31.3%+65.9%$4.17BN/A-17.9130High Trading VolumeTMDXTransMedics Group2.0937 of 5 stars$116.88+3.9%$127.33+8.9%-25.4%$3.95B$441.54M85.94210Positive NewsAnalyst ForecastINSPInspire Medical Systems4.8713 of 5 stars$130.17-0.1%$211.91+62.8%-12.7%$3.84B$802.80M59.981,246Positive NewsAnalyst ForecastNVSTEnvista3.3812 of 5 stars$20.05-0.8%$20.23+0.9%+16.9%$3.40B$2.51B-3.0712,300News CoverageAnalyst RevisionPRCTPROCEPT BioRobotics2.2239 of 5 stars$58.17+2.7%$87.50+50.4%-18.2%$3.22B$249.12M-34.22430Analyst ForecastAnalyst RevisionWRBYWarby Parker2.4888 of 5 stars$23.02+3.7%$22.88-0.6%+32.9%$2.41B$795.09M-191.803,780News CoverageLIVNLivaNova3.1377 of 5 stars$43.97-0.8%$59.29+34.8%-20.3%$2.40B$1.25B-10.752,900News CoverageEYENational Vision2.8865 of 5 stars$25.01+2.2%$22.10-11.6%+83.9%$1.98B$1.82B-75.7913,411NVCRNovoCure3.5491 of 5 stars$17.42-1.0%$32.43+86.2%-14.0%$1.94B$605.22M-11.541,488Upcoming EarningsLMATLeMaitre Vascular2.7018 of 5 stars$84.09+0.5%$97.83+16.3%-5.1%$1.90B$226.26M42.47490News CoveragePositive News Related Companies and Tools Related Companies Soleno Therapeutics Competitors TransMedics Group Competitors Inspire Medical Systems Competitors Envista Competitors PROCEPT BioRobotics Competitors Warby Parker Competitors LivaNova Competitors National Vision Competitors NovoCure Competitors LeMaitre Vascular Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
